In vivo and in vitro growth of SCLC cells derived from biopsies.
In order to increase the availability of SCLC cells derived from biopsies, in vivo and in vitro growth methods were investigated. The cells grown in both conditions were periodically monitored for reactivity with 2 monoclonal antibodies (MAbs): MLuC1 directed against SCLC cells and IM1 which recognizes the class II antigen on activated lymphocytes and macrophages. About 50% of the 28 analyzed SCLC specimens were found to proliferate in one or both systems. The in vitro-grown cells exhibited the same heterogeneity found in the original cell suspensions and moreover, in some cases only normal cells were recovered after several in vitro passages. From the subcutaneous transplanted tumors a large number of MLuC1-positive tumor cells could easily be recovered, thus indicating the validity of the in vivo methodology. The MBr1 MAb, directed against an epithelial antigen, was found to react with about 50% of the 26 tested tumors, mainly those which demonstrated in vivo and/or in vitro growth capacity. These data suggest that only some tumors, presumably with peculiar biological characteristics, can efficiently grow in these artificial systems.
Gianì
S
S
Experimental Oncology E, Istituto Nazionale Tumori, Milano, Italy.
Bedini
V
V
Cataldo
I
I
Iafrate
E
E
Martignone
S
S
Ménard
S
S
Pilotti
S
S
Pratesi
G
G
Soresi
E
E
Colnaghi
M I
MI
D000328:Adult; D000368:Aged; D000818:Animals; D000951:Antigens, Neoplasm / Q000032:analysis; D018288:Carcinoma, Small Cell / Q000473:pathology*; D005260:Female; D006801:Humans; D007070:Immunoglobulin A / Q000096:biosynthesis; D008175:Lung Neoplasms / Q000473:pathology*; D008297:Male; D051379:Mice; D008819:Mice, Nude; D008875:Middle Aged; D009368:Neoplasm Transplantation; D014407:Tumor Cells, Cultured
D000951:Antigens, Neoplasm; D007070:Immunoglobulin A